China

Report: Intelligence proves that Wuhan lab had sick staff as early as November 2019

Published

3 years ago

May 24, 2021

The Wall Street Journal obtained an intelligence report that reportedly revealed three staff members in China’s Wuhan Institute of Virology went to a hospital to be treated “with symptoms consistent with both Covid-19 and common seasonal illness” in the fall of 2019.

One of their anonymous sources is reportedly taking the intelligence very seriously. “The information that we had coming from the various sources was of exquisite quality. It was very precise. What it didn’t tell you was exactly why they got sick,” the source told the Journal.

On the other hand, China continues to deny that the coronavirus came from any of its labs. The foreign ministry continued to deny in a statement to WSJ. “The U.S. continues to hype the lab leak theory. Is it actually concerned about tracing the source or trying to divert attention?”

Read the full article here.

You can follow Jenny Goldsberry on Twitter @jennyjournalism

China

Biden to lift sanctions on China in exchange for third promise to combat fentanyl

Published

3 weeks ago

November 15, 2023

Sara Carter Staff

Reportedly President Joe Biden is making deals with Chinese President Xi Jinping to help improve anti-drug trafficking measures. China is one of the top fentanyl producers and distributors, culminating in a pandemic of fentanyl overdoses and deaths in the United States.

The Biden administration will be lifting sanctions on a Chinese government ministry, in exchange for bolstering anti-drug trafficking measures, Bloomberg reported. “We’re hoping to see some progress on that issue this coming week,” National Security Advisor Jake Sullivan said Monday, according to the New York Post. “That could then open the door to further cooperation on other issues where we aren’t just managing things, but we’re actually delivering tangible results.”

The Daily Caller News Foundation noted that should a deal materialize, it will be at least the third time that China has promised to get tough on fentanyl. In 2016, China agreed to increase counter-narcotics operations, and Xi again agreed to launch a crackdown in 2018. Nonetheless, China and Mexico are “the primary source countries for fentanyl and fentanyl-related substances trafficked directly into the United States,” according to a 2020 DEA intelligence report.

“China remains the primary source of fentanyl and fentanyl-related substances trafficked through international mail and express consignment operations environment, as well as the main source for all fentanyl-related substances trafficked into the United States.”

President Joe Biden and Xi are meeting for the first time in over a year during this week’s Asia Pacific Economic Cooperation (APEC) summit in San Francisco. Sources familiar with the situation told Bloomberg that the People’s Republic of China (PRC) will crack down on Chinese companies manufacturing chemical precursors for fentanyl in exchange for the U.S. lifting sanctions on the Ministry of Public Security’s Institute of Forensic Science, which the Commerce Department added to the Entity List in 2020 for “engaging in human rights violations and abuses” in the Xinjiang Uyghur Autonomous Region.